| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |